CENPA acts as an upstream transcriptional activator of the karyopherin α2 subunit gene (KPNA2), indirectly promoting tumor cell growth and glycolysis in patients with colon cancer (Liang et al., 2021). This evidence concerns the gene KPNA2 and colonic neoplasm.